在肝细胞癌中除氧化酶
Xingyu Mi1, Qingfeng Li2, Guo Long1
1Department of Liver Surgery, Xiangya Hospital, Central South University, 110 Xiangya Road, Changsha, Hunan 410078, China.
International journal of biological sciences
|July 3, 2025
概括
脱化酶 (DUBs) 调节了无处化. 失调的DUB与肝细胞癌 (HCC) 相关,这是一种致命的肝癌,突出了它们作为治疗点的潜力.
科学领域:
- 生物化学和分子生物学
- 在瘤学瘤学.
- 细胞调节 细胞调节 细胞调节
背景情况:
- 细胞中关键的过程 - - 乌比基化,由酶密切控制,其中包括双化酶 (DUBs).
- DUBs的失调破坏了无处不在的平衡,导致各种疾病,特别是癌症.
- 肝细胞癌 (HCC) 是一种具有有限治疗选择的侵袭性肝癌,这凸显了对新型治疗策略的需求.
研究的目的:
- 综述和总结涉及肝细胞癌 (HCC) 的二维基素化酶 (DUB).
- 阐明在HCC开发中DUB的结构,功能和监管机制.
- 提供对潜在的治疗策略的见解,针对HCC中的DUB.
主要方法:
- 对现有的DUB研究及其在HCC中的作用的文献综述.
- 对与癌症生物学相关的DUB结构和功能的分析.
- 对DUBs在HCC病变发生机制的当前知识的综合.
主要成果:
- 许多DUB已被确定为在各种瘤类型中失调,包括HCC.
- 特定的DUB在调节HCC细胞增殖,存活和转移方面发挥着至关重要的作用.
- 许多DUBs影响HCC的确切机制仍然不完全理解.
结论:
- DUBs代表了肝细胞癌治疗点的有希望的类别.
- 需要进一步研究DUB在HCC中的特定作用和机制.
- 了解DUB为开发创新的HCC治疗提供了新的途径.
相关概念视频
The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
Drug Metabolism: Phase II Reactions
4.2K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.2K


